Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer.

Sandro Wagner; Teresa Magnes; Thomas Melchardt; Dominik Kiem; Lukas Weiss; Daniel Neureiter; Christina Wagner; Marie-Bernadette Aretin; Stefan Nemec; Gabriele Gamerith; Georg Pall; Richard Greil; Thorsten Fuereder

doi:10.21873/anticanres.16274

Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer.

Sandro Wagner (Erstautor/-in), Teresa Magnes (Co-Autor/-in), Thomas Melchardt (Co-Autor/-in), Dominik Kiem (Co-Autor/-in), Lukas Weiss (Co-Autor/-in), Daniel Neureiter (Co-Autor/-in), Christina Wagner, Marie-Bernadette Aretin, Stefan Nemec, Gabriele Gamerith, Georg Pall, Richard Greil^* (Co-Autor/-in), Thorsten Fuereder

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsinstitut für Pathologie
Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

5 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	1273-1282
Fachzeitschrift	ANTICANCER RESEARCH
Jahrgang	43
Ausgabenummer	3
DOIs	https://doi.org/10.21873/anticanres.16274
Publikationsstatus	Veröffentlicht - 2023

Zugriff auf Dokument

10.21873/anticanres.16274

Dieses zitieren

Wagner, S., Magnes, T., Melchardt, T., Kiem, D., Weiss, L., Neureiter, D., Wagner, C., Aretin, M.-B., Nemec, S., Gamerith, G., Pall, G., Greil, R., & Fuereder, T. (2023). Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer. ANTICANCER RESEARCH , 43(3), 1273-1282. https://doi.org/10.21873/anticanres.16274

Wagner, Sandro ; Magnes, Teresa ; Melchardt, Thomas et al. / Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer. in: ANTICANCER RESEARCH 2023 ; Jahrgang 43, Nr. 3. S. 1273-1282.

@article{29df18ef215244cfa2396840f153f349,

title = "Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer.",

keywords = "SQUAMOUS-CELL CARCINOMA, CLONAL EVOLUTION, OPEN-LABEL, LUNG-CANCER, PEMBROLIZUMAB, CHEMOTHERAPY, CETUXIMAB, RECURRENT, HETEROGENEITY, CISPLATIN",

author = "Sandro Wagner and Teresa Magnes and Thomas Melchardt and Dominik Kiem and Lukas Weiss and Daniel Neureiter and Christina Wagner and Marie-Bernadette Aretin and Stefan Nemec and Gabriele Gamerith and Georg Pall and Richard Greil and Thorsten Fuereder",

note = "Wagner, Magnes, Melchardt, Kiem, Weiss, Greil: III Medical Department at the Paracelsus Medical University, Salzburg, Austria; Neureiter: Institute of Pathology, Paracelsus Medical University, Salzburg, Austria; keine Aff. zum Kardinal Schwarzenberg ",

year = "2023",

doi = "10.21873/anticanres.16274",

language = "English",

volume = "43",

pages = "1273--1282",

journal = "ANTICANCER RESEARCH ",

issn = "0250-7005",

number = "3",

}

Wagner, S , Magnes, T , Melchardt, T , Kiem, D , Weiss, L , Neureiter, D, Wagner, C, Aretin, M-B, Nemec, S, Gamerith, G, Pall, G, Greil, R & Fuereder, T 2023, 'Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer.', ANTICANCER RESEARCH , Jg. 43, Nr. 3, S. 1273-1282. https://doi.org/10.21873/anticanres.16274

Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer. / Wagner, Sandro (Erstautor/-in); Magnes, Teresa (Co-Autor/-in); Melchardt, Thomas (Co-Autor/-in) et al.
in: ANTICANCER RESEARCH , Jahrgang 43, Nr. 3, 2023, S. 1273-1282.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer.

AU - Wagner, Sandro

AU - Magnes, Teresa

AU - Melchardt, Thomas

AU - Kiem, Dominik

AU - Weiss, Lukas

AU - Neureiter, Daniel

AU - Wagner, Christina

AU - Aretin, Marie-Bernadette

AU - Nemec, Stefan

AU - Gamerith, Gabriele

AU - Pall, Georg

AU - Greil, Richard

AU - Fuereder, Thorsten

N1 - Wagner, Magnes, Melchardt, Kiem, Weiss, Greil: III Medical Department at the Paracelsus Medical University, Salzburg, Austria; Neureiter: Institute of Pathology, Paracelsus Medical University, Salzburg, Austria; keine Aff. zum Kardinal Schwarzenberg

PY - 2023

Y1 - 2023

KW - SQUAMOUS-CELL CARCINOMA

KW - CLONAL EVOLUTION

KW - OPEN-LABEL

KW - LUNG-CANCER

KW - PEMBROLIZUMAB

KW - CHEMOTHERAPY

KW - CETUXIMAB

KW - RECURRENT

KW - HETEROGENEITY

KW - CISPLATIN

U2 - 10.21873/anticanres.16274

DO - 10.21873/anticanres.16274

M3 - Original Article (Journal)

C2 - 36854497

SN - 0250-7005

VL - 43

SP - 1273

EP - 1282

JO - ANTICANCER RESEARCH

JF - ANTICANCER RESEARCH

IS - 3

ER -

Wagner S , Magnes T , Melchardt T , Kiem D , Weiss L , Neureiter D et al. Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer. ANTICANCER RESEARCH . 2023;43(3):1273-1282. doi: 10.21873/anticanres.16274